Insider · CIK 0001607733

HAUMANN BRETT K

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001607733

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−35.7K sh	$18.79	−$670K	242,499
2020-11-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−4,639 sh	$17.21	−$79.8K	278,171
2020-10-13	Aimmune Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−13.3K sh	$34.50	−$459K	0
2020-10-13	Aimmune Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25.5K sh	$17.39	−$443K	0
2020-10-10	Aimmune Therapeutics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−6,250 sh	$34.50	−$216K	0
2020-08-21	TBPHTheravance Biopharma, Inc.S Sale	Chief Medical Officer	SSale	−25K sh	$18.29	−$457K	282,810
2020-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−4,646 sh	$18.22	−$84.7K	307,810
2020-05-27	Aimmune Therapeutics, Inc.A Award	Director	AAward	+13.3K sh	—	—	19,563
2020-05-27	Aimmune Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+25.5K sh	—	—	25,453
2020-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−4,212 sh	$26.67	−$112K	312,456
2020-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−33.6K sh	$25.90	−$870K	316,668
2020-02-03	TBPHTheravance Biopharma, Inc.A Award	Chief Medical Officer	AAward	+65K sh	—	—	296,276
2020-02-03	TBPHTheravance Biopharma, Inc.A Award	Chief Medical Officer	AAward	+54K sh	—	—	350,276
2019-11-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−2,692 sh	$17.60	−$47.4K	231,276
2019-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−2,710 sh	$21.51	−$58.3K	233,968
2019-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−2,705 sh	$19.84	−$53.7K	236,678
2019-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−7,778 sh	$27.00	−$210K	239,383
2019-02-05	TBPHTheravance Biopharma, Inc.A Award	Chief Medical Officer	AAward	+65K sh	—	—	199,911
2019-02-05	TBPHTheravance Biopharma, Inc.A Award	Chief Medical Officer	AAward	+47.3K sh	—	—	247,161
2018-11-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−7,368 sh	$24.79	−$183K	134,911
2018-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−6,683 sh	$26.95	−$180K	142,279
2018-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−27K sh	$24.31	−$656K	148,962
2018-05-14	TBPHTheravance Biopharma, Inc.A Award	Chief Medical Officer	AAward	+33.8K sh	—	—	175,953
2018-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−8,293 sh	$29.09	−$241K	142,203
2018-02-12	TBPHTheravance Biopharma, Inc.A Award	Chief Medical Officer	AAward	+9,000 sh	—	—	150,496
2017-11-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−7,846 sh	$28.58	−$224K	141,496
2017-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−7,064 sh	$27.40	−$194K	149,342
2017-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−7,065 sh	$36.83	−$260K	156,406
2017-03-07	TBPHTheravance Biopharma, Inc.S Sale	Chief Medical Officer	SSale	−424 sh	$30.80	−$13.1K	163,471
2017-03-06	TBPHTheravance Biopharma, Inc.S Sale	Chief Medical Officer	SSale	−13.6K sh	$31.52	−$428K	163,895
2017-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−14.4K sh	$33.78	−$488K	177,471
2017-02-06	TBPHTheravance Biopharma, Inc.A Award	Chief Medical Officer	AAward	+9,000 sh	—	—	191,905
2016-11-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−5,388 sh	$31.96	−$172K	182,905
2016-08-25	TBPHTheravance Biopharma, Inc.S Sale	Chief Medical Officer	SSale	−4,491 sh	$27.99	−$126K	188,293
2016-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−4,607 sh	$27.89	−$128K	192,784
2016-08-19	TBPHTheravance Biopharma, Inc.S Sale	Chief Medical Officer	SSale	−9,509 sh	$27.97	−$266K	197,391
2016-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−4,608 sh	$20.55	−$94.7K	206,900
2016-03-15	TBPHTheravance Biopharma, Inc.A Award	Chief Medical Officer	AAward	+90K sh	—	—	211,508
2016-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−18.4K sh	$15.65	−$288K	121,508
2015-11-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−781 sh	$17.17	−$13.4K	139,933
2015-02-05	TBPHTheravance Biopharma, Inc.A Award	Chief Medical Officer	AAward	+135K sh	—	—	140,714

Recent filings

Accepted (ET)
Feb 234
HAUMANN BRETT K0001179110-21-002157
SEC(opens sec.gov)
Nov 244
HAUMANN BRETT K0001179110-20-011367
SEC(opens sec.gov)
Oct 144
HAUMANN BRETT K0000899243-20-028178
SEC(opens sec.gov)
Aug 244
HAUMANN BRETT K0001179110-20-009263
SEC(opens sec.gov)
May 294
HAUMANN BRETT K0000899243-20-014618
SEC(opens sec.gov)
May 224
HAUMANN BRETT K0001179110-20-006524
SEC(opens sec.gov)
Feb 244
HAUMANN BRETT K0001179110-20-002143
SEC(opens sec.gov)
Feb 54
HAUMANN BRETT K0001179110-20-001198
SEC(opens sec.gov)
Nov 224
HAUMANN BRETT K0001179110-19-012013
SEC(opens sec.gov)
Aug 224
HAUMANN BRETT K0001179110-19-009785
SEC(opens sec.gov)
May 224
HAUMANN BRETT K0001179110-19-006520
SEC(opens sec.gov)
Feb 224
HAUMANN BRETT K0001179110-19-002409
SEC(opens sec.gov)
Feb 74
HAUMANN BRETT K0001179110-19-001558
SEC(opens sec.gov)
Nov 214
HAUMANN BRETT K0001179110-18-013106
SEC(opens sec.gov)

Companies

Address

C/O THERAVANCE BIOPHARMA US, INC. 901 GATEWAY BLVD

SOUTH SAN FRANCISCO, CA, 94080